356 related articles for article (PubMed ID: 21902680)
1. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Johansson B; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E
Br J Haematol; 2011 Oct; 155(2):235-43. PubMed ID: 21902680
[TBL] [Abstract][Full Text] [Related]
2. Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol.
Kuchinskaya E; Heyman M; Nordgren A; Söderhäll S; Forestier E; Wehner P; Vettenranta K; Jonsson O; Wesenberg F; Sahlén S; Nordenskjöld M; Blennow E
Br J Haematol; 2011 Mar; 152(5):615-22. PubMed ID: 21241277
[TBL] [Abstract][Full Text] [Related]
3. Interphase FISH to detect PBX1/E2A fusion resulting from the der(19)t(1;19)(q23;p13.3) or t(1;19)(q23;p13.3) in paediatric patients with acute lymphoblastic leukaemia.
Shearer BM; Flynn HC; Knudson RA; Ketterling RP
Br J Haematol; 2005 Apr; 129(1):45-52. PubMed ID: 15801954
[TBL] [Abstract][Full Text] [Related]
4. High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies.
Vaitkevičienė G; Forestier E; Hellebostad M; Heyman M; Jonsson OG; Lähteenmäki PM; Rosthoej S; Söderhäll S; Schmiegelow K;
Eur J Haematol; 2011 Jan; 86(1):38-46. PubMed ID: 21077959
[TBL] [Abstract][Full Text] [Related]
5. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival.
Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Rosenquist R; Swolin B; Johansson B; ; ;
Br J Haematol; 2008 Mar; 140(6):665-72. PubMed ID: 18241254
[TBL] [Abstract][Full Text] [Related]
6. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B
Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335
[TBL] [Abstract][Full Text] [Related]
7. Formation of der(19)t(1;19)(q23;p13) in acute lymphoblastic leukemia.
Paulsson K; Horvat A; Fioretos T; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2005 Feb; 42(2):144-8. PubMed ID: 15543624
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group.
Forestier E; Johansson B; Gustafsson G; Borgström G; Kerndrup G; Johannsson J; Heim S
Br J Haematol; 2000 Jul; 110(1):147-53. PubMed ID: 10930992
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
10. Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol.
Barbany G; Andersen MK; Autio K; Borgström G; Franco LC; Golovleva I; Heim S; Heinonen K; Hovland R; Johansson B; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E; ; ;
Leuk Res; 2012 Jul; 36(7):936-8. PubMed ID: 22521551
[No Abstract] [Full Text] [Related]
11. Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature.
Forestier E; Gauffin F; Andersen MK; Autio K; Borgström G; Golovleva I; Gustafsson B; Heim S; Heinonen K; Heyman M; Hovland R; Johannsson JH; Kerndrup G; Rosenquist R; Schoumans J; Swolin B; Johansson B; Nordgren A; ; ;
Genes Chromosomes Cancer; 2008 Feb; 47(2):149-58. PubMed ID: 17990329
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia.
Secker-Walker LM; Berger R; Fenaux P; Lai JL; Nelken B; Garson M; Michael PM; Hagemeijer A; Harrison CJ; Kaneko Y
Leukemia; 1992 May; 6(5):363-9. PubMed ID: 1593901
[TBL] [Abstract][Full Text] [Related]
13. Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: rare T-cell receptor gene rearrangements are associated with poor outcome.
Karrman K; Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Ehrencrona H; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Palmqvist L; Johansson B; ; ;
Genes Chromosomes Cancer; 2009 Sep; 48(9):795-805. PubMed ID: 19530250
[TBL] [Abstract][Full Text] [Related]
14. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
[TBL] [Abstract][Full Text] [Related]
15. Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K
Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790
[TBL] [Abstract][Full Text] [Related]
16. Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in ALL (acute lymphoblastic leukemia) cured patients.
Brassesco MS; Camparoto ML; Tone LG; Sakamoto-Hojo ET
Cytogenet Genome Res; 2004; 104(1-4):346-51. PubMed ID: 15162063
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Heerema NA; Sather HN; Sensel MG; Lee MK; Hutchinson R; Nachman JB; Lange BJ; Steinherz PG; Bostrom B; Gaynon PS; Uckun FM
Cancer; 2000 Apr; 88(8):1945-54. PubMed ID: 10760773
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
19. High incidence of the ETV6/RUNX1 fusion gene in paediatric precursor B-cell acute lymphoblastic leukaemias with trisomy 21 as the sole cytogenetic change: a Nordic series of cases diagnosed 1989-2005.
Karrman K; Forestier E; Andersen MK; Autio K; Borgström G; Heim S; Heinonen K; Hovland R; Kerndrup G; Johansson B;
Br J Haematol; 2006 Nov; 135(3):352-4. PubMed ID: 16965388
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy.
Pichler H; Möricke A; Mann G; Teigler-Schlegel A; Niggli F; Nebral K; König M; Inthal A; Krehan D; Dworzak MN; Janousek D; Harbott J; Schrappe M; Gadner H; Strehl S; Haas OA; Panzer-Grümayer R; Attarbaschi A;
Br J Haematol; 2010 Apr; 149(1):93-100. PubMed ID: 20067563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
